Company Kallo Inc.

Equities

KALO

US48343P2083

Advanced Medical Equipment & Technology

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Medical Software & Technology Services

Delayed OTC Markets Other stock markets 14:43:24 18/12/2023 GMT			5-day change	1st Jan Change
0.0003 ^USD	-.--%		-.--%	-.--%

2022	Kallo Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
2022	Kallo Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI

Kallo Inc. offers a healthcare delivery program. Its healthcare delivery program provides advanced healthcare solution that is customized to each country including infectious disease management and customized education and training programs. The Companyâs technology suite transforms healthcare delivery through rural healthcare, disease management, clinical globalization, and e-health solutions. Its telehealth program is a technology connected to its global network of physicians, nurse practitioners, pharmacists, specialists, and surgeons specialized in minimal invasive procedures on a federated model. The telehealth program facilitates synchronous and asynchronous interactions where patients and staff are in different locations. Its maintenance services program includes three components: Biomedical Engineering services, Mechanical and Electrical Engineering services, and Information and Communications Technology.

Number of employees: 3

Managers	Title	Age	Since
John Cecil CEO	Chief Executive Officer	62	11/12/06
Marion B. Lyver CTO	Chief Tech/Sci/R&D Officer	-	30/11/14
Lloyd Chiotti COO	Chief Operating Officer	76	21/09/11
Samuel Baker BRD	Director/Board Member	89	30/12/09
Edward DaSilva PRN	Corporate Officer/Principal	-	-
Chris Barry PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Samuel Baker BRD	Director/Board Member	89	30/12/09
John Cecil CEO	Chief Executive Officer	62	11/12/06
Lloyd Chiotti COO	Chief Operating Officer	76	21/09/11

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	6,356,429,204	2,448,755,751 ( 38.52 %)	0	38.52 %
Stock B	0	95,000,000	0	0

Name	Equities	%	Valuation
John Cecil -	70,000,000	-	70 000 $
Lloyd Chiotti -	5,000,000	-	5 000 $

Kallo, Inc.

255 Duncan Mill Road Suite 504

M3B 3H9, Toronto

http://www.kalloinc.ca

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Software & Technology Services

	1st Jan change	Capi.
KALLO INC.	-.--%	1.91M
VEEVA SYSTEMS INC.	+6.14%	32.95B
PRO MEDICUS LIMITED	+20.16%	8.09B
SECTRA AB	+31.03%	4B
EVOLENT HEALTH, INC.	-25.72%	3.09B
OMNICELL, INC.	-21.61%	1.39B
LUNIT INC.	-31.87%	1.19B
SIMULATIONS PLUS, INC.	+6.64%	966M
B-SOFT CO.,LTD.	-35.73%	933M
VERADIGM INC.	-25.17%	834M

Medical Software & Technology Services